CTLA4 and osteosarcoma: For example, we reported the phenomenon of tumor infiltrating Treg decreasing after administering anti-PD-1 antibody in an osteosarcoma cell line transplanted mouse model and considered it to be the result of ADCC with Treg expressing PD-1, as the same as the anti-CTLA4 antibody [78].